Precisionbiotics Group Limited

Alimentary Health Limited

The Procter Gamble Company

University College Cork

Eileen Frances Murphy

Barry Kiely

Liam Diarmuid O'Mahony

John Francis Cryan

Timothy Dinan

Jose Carlos Garcia-Garcia

Michael John Janusz

David Groeger

Selena Healy

Huiying Wang

Christoph Braun

Paul Enck

Liam O'mahony

strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.

NCIMB 41676

The strainAH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.

for treating obesity and associated metabolic disorders

A combination product comprising an isolated strain ofNCIMB 41003 and another strain which does not adversely interact withNCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.

Combination product for prophylaxis and treatment of irritable bowel syndrome

Probioticstrain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.

Probioticstrain

AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.

Methods of treating a subject by administeringstrain NCIMB 41676 are discussed. The method may include orally administering a formulation comprisingstrain NCIMB 41676 to improve sleep.

Probiotic bifidobacterium strain

A formulation comprising an ingestible carrier and an isolated strain of

Growing community of inventors

Cork, Ireland

Eileen Frances Murphy